October 19-20, 2016

Featured Speakers

Nat Katz, MD, MS, Chief Executive Officer, Analgesic Solutions
Stephen Waxman, MD, Ph.D., Bridget Marie Flaherty Prof. of Neurology, Neurobiology, & Pharmacology, Yale University School of Medicine
Neil Castle, Ph.D., Director of Biology, Icagen
Carl Noe, MD, Prof., Dept. of Pain Management & Anesthesiology, UT Southwestern Medical Center
2011i.gif 2011ii.JPG 2011iii.JPG 2014i.JPG 2014ii.JPG 2014iii.JPG 2015i.JPG 2015ii.JPG

About the Conference

ARROWHEAD’S ANNUAL PAIN & MIGRAINE THERAPEUTICS SUMMIT is the US’s premier pain conference covering the field of pain research and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors.
This conference provides attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including:
♦ New research in genome-wide association studies
♦ CGRP antagonists
♦ NGF antagonists
♦ Sodium and calcium channel blockers
♦ New research in biologic therapies
♦ The genetic components of pain
♦ Abuse-resistant opioids
♦ Analysis of FDA’s REMS program
...and a plethora of other topics.

Join our Social Media Groups on LinkedIn and Twitter

  Pain Drug Development Group                 @PainConference

Download Brochure

Speaking Opportunities

Sponsor/Exhibit Opportunities

Join Conference Mailing List

Networking Opportunities

Attendees will have the opportunity to network and get to know each other before during and after the event through the following:
  • OUR CONFERENCE NETWORKING WEBSITE is online weeks prior to the event. Attendees can schedule one-on-one meetings prior to the conference and print out a schedule of meeting times during the conference.
  • EXTENDED NETWORKING BREAKS. These will give attendees the chance to meet those with whom they many not have set up meetings.
  • SPEAKER Q&A SESSIONS. This will afford attendees the opportunity to ask additional questions of our speakers.
  • EVENING RECEPTION. This will give attendees the chance to mingle with other professionals after a day full of speakers, meetings, and thought-provoking topics.

Reasons to Attend

LEARN about the latest developments and the most recent commercial breakthroughs in the area of pain therapeutics
GAIN a better sense of the impact the biotech industry is having on the development of pain therapeutics
DISCOVER what innovative new therapies are driving investment and clinical development in the area of pain therapeutics
NETWORK with leaders from the pharma, biotech, specialty pharma and drug delivery industries as well as the academic community and government
BETTER UNDERSTAND the specific and implications of groundbreaking new research in the field of pain therapeutics
ACQUIRE a holistic view of the field of pain therapeutics from the perspective of scientists, clinicians and commercial executives

Testimonials from the 2015 Summit

I enjoyed the experience and thought the program was a lovely balance of topics across advances in the development space and in the laboratory. The ease to meet and speak to people was also excellent.
Nick Andrews, Instructor and Manager, <strong>Boston Children's Hospital/Harvard Medical School</strong>
Nick Andrews, Instructor and Manager, Boston Children's Hospital/Harvard Medical School

The Arrowhead Summit is a comprehensive mix of the latest in pre-clinical, mechanistic work in pain drug development along with a nice overview of current clinical trial advancements in this therapeutic area.
Paul Blahunka, Global Development Project Leader, <strong>Astellas</strong>
Paul Blahunka, Global Development Project Leader, Astellas

A great meeting to get to know those on the forefront of pain development.
Mike Royal, EVP, Clinical & Regulatory Affairs, <strong>Sorrento Therapeutics</strong>
Mike Royal, EVP, Clinical & Regulatory Affairs, Sorrento Therapeutics

I very much enjoyed the scientific content and the size of the meeting.
Carol Meschter, <strong>Comparative Biosciences, Inc.</strong>
Carol Meschter, Comparative Biosciences, Inc.

This is always a delightful and informative session.
Steve Shulman, Assistant Clinical Professor of Anesthesiology and Pain Medicine, <strong>Rutgers-NJMS/Newark</strong>
Steve Shulman, Assistant Clinical Professor of Anesthesiology and Pain Medicine, Rutgers-NJMS/Newark

It is a nice snapshot of scientific activity and a look at what may be on the horizon in the pain space.
Nicole McGrew, Project Director, <strong>INC Research</strong>
Nicole McGrew, Project Director, INC Research

The conference was a very well balanced session with high quality, innovative attendees, informative sessions and great organization. I'm excited for next year's conference.
Christopher Frankiewicz, Research Scientist, <strong>Chromocell Corporation</strong>
Christopher Frankiewicz, Research Scientist, Chromocell Corporation

Who Attends

Abbott Laboratories | Acura Pharmaceuticals | Adolor Corporation | Adynxx Inc. | Aestus Therapeutics | Afferent Pharmaceuticals | AIT Laboratories | Alder Biopharmaceuticals | Algos Preclinical Services | Alta Life Sciences LLC | Ameritox | Amgen | Anabios Corporation | Analgesic Solutions | Anvyl LLC | Archimedes Pharma | Arcion Therapeutics | Array Biopharma | Astellas Pharma Europe | AstraZeneca | Atlantic Pharmaceuticals Inc | Avigen | Benitec Biopharma | BioAssets Development Corporation | Biogen Idec | BioLineRx | Bionomics | bvBiovail | BioVasc Inc. | Cadence Pharmaceuticals | Camargo Pharma Services | Cambridge Consultants Ltd. | Cara Therapeutics | Cardiome Pharma Corp. | Carnegie Mellon University | Celgene Corp. | Cephalon, Inc. | CG Pharmaceuticals | ChanTest | Chromocell Corporation | Clinical Trial Centers | Clinsys Clinical Research | CNS Drug Consulting | CNSBio Inc. | COLLEGIUM Pharma | Covidien | CRI Lifetree | CRI Worldwide | CrystalGenomics, Inc. | Cubist Pharmaceuticals | DARA BioSciences, Inc | Decision Line Clinical | Defined Health | Dendreon Corporation | Depomed | Domain Associates | Dr. Kade Pharma GmbH | Dr. Reddy's Laboratories | DURECT Corporation | Elanco Animal Health | Eli Lilly & Co | Ethypharm USA | Eurand | Eurofins Prod Safety Labs | FDA | Forest Research Institute | Franklin Pharmacy | Genentech | Genzyme | GIST | GlaxoSmithKline | Glenmark Therapeutics Inc. | Grünenthal GmbH | GVK Biosciences | GW Pharma | Hospira, Inc. | Hydra Biosciences | i3 Research | Icagen | ICON Development | I-Flow, LLC | Indiana University | INFARMED, .I.P. | Integrated Circle of Care Inc. | Ironwood Pharmaceuticals | Isis Pharmaceuticals | J. Bolen Group, LLC | Janssen Pharmaceuticals | Janssen Research | Javelin Pharmaceuticals | Jennersville Hospital | Johnson & Johnson Pharmaceutical | KAI Research Inc. | KCI | King Pharmaceuticals | Labopharm Inc. | Lotus Clinical Research | Lpath | Mass. General Hospital | McGill University | McLean Hospital | MD Biosciences | MedImmune | Medtox Laboratories | Medtronic | Merck & Co., Inc. | Millipore | Mitsubishi Tanabe | MRC Technology | Natixis Bleichroeder | Nektar Therapeutics | NeurAxon | NeuroDiscovery Group | Neuromed | Newron Pharma | NINR, NIH | NMS Labs | North Star Consulting | NovaBay Pharma | Noveida | Nuvo Research | Nycomed | NYU School of Medicine | Omneuron, Inc. | Orexo AB | Origin BioMed Inc. | Ormskirk Hospital | Pacira Pharmaceuticals | Pain Ceptor Pharma | Pain Insights, Inc. | Pain Research Forum | PainReform | Pappas Ventures | PAREXEL International | Pfizer VMRD | PharmacoFore | PharmaNet-i3 | Pharmidex | Phosphagenics | PLX Pharma | Precise Clinical Research | Premier Research | Prescription Drug Research Center | Product Safety Labs | PsychoGenics Inc. | Purdue Pharma | QRx Pharma | Radical Group | Regeneron | Regeneron Pharmaceuticals | ResearchPoint | Ricerca Biosciences | RoxRo Pharma | sanofi Aventis | Schwarz BioSciences | SCOLR Pharma | Scripps Research Institute | Sepracor | Shaare Zedec Medical Center | Shire Pharmaceuticals | Solimar Therapeutics, Inc. | St. Louis University | Stanford Pain Medicine Center | Stanford University | Stanford University School of Medicine | Studylog Systems | Sungsil University | Sunovion Pharmaceticals| Susquehanna Financial | Synergenics, LLC | Synergy Clinical Research | Syntaxin Ltd | Takeda Pharmaceutical Company | Temple Univ. Beasley School of Law | Temple University School of Pharmacy | Teva Pharmaceuticals | The May Day Fund |The Pain Treatment Center of the Bluegrass | The Scripps Research Institute | Theorem Clinical Research | TheraQuest Biosciences | Theravance | Trevena Inc. | Trillium Medical Ventures | Trinity Partners | U. Iowa Carver College of Med., Dept. of Pharmacology & Anesthesia | UC Davis | UCSD | UCSF | UMDNJ | University of Adelaide | University of Arizona | University of California San Francisco | University of California, Irvine | University of Kentucky | University of Pittsburgh | University of Rochester Medical Center | Vertex Pharmaceuticals | Victory Pharma | Vince and Associates Clinical Research | Vivozon, Inc | VM Pharma | Washington University | Washington University in St. Louis | Wright State University School of Medicine | Wyeth | Wyeth Research | Xalud Therapeutics | Xanodyne Pharmaceuticals | Xenome | Xenon Pharmaceuticals Inc. | XenoPort | Zalicus | Zogenix

About Us

Arrowhead Publishers' conferences offer more than simply presentations; we offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward. 

Contact Us

For general information about the conference, please contact us at:
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 5780 Lincoln Drive, Suite 205, Edina, Minnesota 55436 USA